Apr 19, 2020
CRISPR Therapeutics braces for ‘severe impact’ from COVID-19 crisis
Posted by Saúl Morales Rodriguéz in category: biotech/medical
April 1, 2020
It was supposed to be an exciting time of next-gen science, where CRISPR gene editing was being used in the first series of human trials in the hope this tech could help cure a range of diseases.
But one of its proponents, CRISPR Therapeutics, has, alongside a growing number of biopharmas, admitted the spreading COVID-19 pandemic is starting to see it be “adversely affected.”
Continue reading “CRISPR Therapeutics braces for ‘severe impact’ from COVID-19 crisis” »